Clinical Trials Logo

Clinical Trial Summary

The objective of this study is to evaluate Lung Doppler signals (LDS) among patients presenting to the emergency department with acute dyspnea, in order to determine the diagnostic value of this non-invasive method to discriminate ADHF causing dyspnea from any other cause i.e., non-ADHF causes of dyspnea.


Clinical Trial Description

Dyspnea (shortness of breath) is a common symptom affecting as many as 25% of patients seen in ambulatory settings. It can be caused by many different underlying conditions, some of which arise acutely and can be life-threatening, making rapid clinical evaluation and targeted diagnostic studies of central importance. A number of disorders cause dyspnea, including acute decompensated heart failure (ADHF), chronic obstructive pulmonary disease (COPD), asthma, pulmonary embolism, pneumonia, metabolic acidosis, neuromuscular weakness, and others. The overlapping clinical presentations of these conditions and comorbid diseases can make the diagnostic evaluation of dyspnea a significant challenge. Acute heart failure (AHF) is a major cause of serious morbidity and death in the general population and one of the most common medical causes of hospitalization among people aged over 60. Patients presenting to the ED with ADHF must be evaluated and treated rapidly to ensure the best possible outcomes. The diagnosis should be made as soon as possible and therapy initiated. Delayed diagnosis at presentation may also result in patients being inappropriately transferred to non-specialist wards, resulting in longer stays, increased re-admission and poorer outcomes. The key to improving the time to diagnosis depends on the clinical evaluation alongside a readiness to initiate relevant additional tests. Previous studies showed that the TPD has the potential to differentiate between the cardiac cause of dyspnea and any other cause. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT03998410
Study type Interventional
Source Echosense Ltd.
Contact
Status Terminated
Phase N/A
Start date September 15, 2019
Completion date December 1, 2021

See also
  Status Clinical Trial Phase
Enrolling by invitation NCT02003040 - Role of the Mespere Venus 1000 in Predicting Heart Failure Hospital Readmissions N/A
Unknown status NCT01700023 - 3-dimensional Sensor Technology to Quantify Leg-edema N/A
Completed NCT01316432 - PK/PD Study of Subcutaneous Cenderitide Infusion in CHF Patients Phase 1
Recruiting NCT04905160 - Care Coordination to Assess Improvement in Outcomes in Hospital Readmissions N/A
Recruiting NCT05677100 - Diuretics Alone vs. Aortix Endovascular Device for Acute Heart Failure N/A
Completed NCT01419132 - Troponin I Release After High Diuretic Doses Phase 4
Recruiting NCT06169540 - Salivary Extracellular Vesicle Associated lncRNAs in Heart Failure (SEAL-HF)